Evidence map›Paper›PMID 29760807›Full record

ArticleJournal of Cancer2018

Quality Control of Next-generation Sequencing-based

Donglai Liu, Haiwei Zhou, Dawei Shi, Shu Shen, Yabin Tian, Lin Wang, Jiatao Lou, Rong Cong, Juan Lu, Henghui Zhang and 9 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Donglai LiuDivision II of In vitro Diagnostics for Infectious Diseases, Institute for In vitro Diagnostics Control, National Institutes for Food and Drug Control, Beijing, China.
Haiwei ZhouDivision II of In vitro Diagnostics for Infectious Diseases, Institute for In vitro Diagnostics Control, National Institutes for Food and Drug Control, Beijing, China.
Dawei ShiDivision II of In vitro Diagnostics for Infectious Diseases, Institute for In vitro Diagnostics Control, National Institutes for Food and Drug Control, Beijing, China.
Shu ShenDivision II of In vitro Diagnostics for Infectious Diseases, Institute for In vitro Diagnostics Control, National Institutes for Food and Drug Control, Beijing, China.
Yabin TianDivision II of In vitro Diagnostics for Infectious Diseases, Institute for In vitro Diagnostics Control, National Institutes for Food and Drug Control, Beijing, China.
Lin WangDepartment of Laboratory Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.
Jiatao LouDepartment of Laboratory Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.
Rong CongGenoSaber Biotech Co. Ltd., Shanghai, China.
Juan LuGenoSaber Biotech Co. Ltd., Shanghai, China.
Henghui ZhangGenecast Precision Medicine Technology Institute, Beijing, China.
Meiru ZhaoGeneplus-Beijing, Beijing, China.
Shida ZhuBGI-Shenzhen, Shenzhen, China.
Zhisheng CaoNovogene Bioinformatics Technology Co., Ltd., Beijing, China.
Ruilin JinAnnoroad Gene Technology Co., Ltd., Beijing, China.
Yin WangBerry Genomics Co., Ltd., Beijing, China.
Xiaoni ZhangHaploX Biotechnology Co., Ltd., Shenzhen, China.
Guohua YangGenoSaber Biotech Co. Ltd., Shanghai, China.
Youchun WangDivision II of In vitro Diagnostics for Infectious Diseases, Institute for In vitro Diagnostics Control, National Institutes for Food and Drug Control, Beijing, China.
Chuntao ZhangDivision II of In vitro Diagnostics for Infectious Diseases, Institute for In vitro Diagnostics Control, National Institutes for Food and Drug Control, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

circulating tumor DNAformalin-fixed paraffin-embedded.next-generation sequencingreference materials

Identifiers

PMID29760807
PMCPMC5950598

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.